Industries

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

22 Jun 2022  |  Global  |  Market Research

Global Operating Room Devices and Solutions Growth Opportunities

Emerging Business Models & Strategies for Cash-strapped Hospitals

Infographics

×

Hospitals are under extreme pressure to reduce costs and increase profits. Considering today’s uncertain regulatory climate and challenging economic environment, medical device companies are challenged to provide products and services to hospitals at an affordable cost. The operating room (OR) offers many opportunities to do so. ORs drive approxima...

Health equity is achieved when all sections of the population have attained their full potential for health and well-being, regardless of cultural background or socioeconomic status. Inequities resulting from differences in health and overall living conditions need to be identified and removed to realize health equity. Monitoring health inequity pa...

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

31 May 2022  |  North America  |  Market Research

Global RNA Therapeutics Growth Opportunities

Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas

Infographics

×

Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessin...

The use case for commercial AI in medical imaging focuses on workflow productivity and diagnostic accuracy in a radiology set up. The impending shortage of radiologists, burnout from a constantly growing imaging workload, and higher investments (by both public and private groups) favor the adoption of AI in medical imaging. Several medical imaging ...

Over the years, the healthcare industry has developed several unique technologies for emergency medical services and critical care. An important user of critical care healthcare products is the military or the defense forces. Advanced medical technologies have improved the care that is offered, and they also enable safer and quicker care for soldie...

16 May 2022  |  North America  |  Market Research

Global Interventional X-ray (IXR) Growth Opportunities

Combining Interventional X-ray and Surgical C-arm with Image-guided Therapies will Accelerate Transformational Growth

Infographics

×

This Frost & Sullivan study analyzes the global interventional X-ray (IXR) market. The research scope includes market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing RoI, critical unmet needs and potential game-changing strategies, growth opportunities for fixed IXR and surgical C-arm s...

NGS library preparation incorporates processing steps that convert genomic DNA or RNA into an appropriate format for the selected sequencing technology. The workflow starts with isolating nucleic acids, fragmented, end-repaired, and connected to adapters using methods like ligation or tagmentation. Sequencing applications incorporate whole genome, ...